Sysmex ADR Research and Development Expenses 2016-2023 | SSMXY
Sysmex ADR annual/quarterly research and development expenses history and growth rate from 2016 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Sysmex ADR research and development expenses for the quarter ending December 31, 2023 were $M, a 100% decline year-over-year.
- Sysmex ADR research and development expenses for the twelve months ending December 31, 2023 were $0.155B, a 4.6% decline year-over-year.
- Sysmex ADR annual research and development expenses for 2023 were $0.23B, a 3.58% decline from 2022.
- Sysmex ADR annual research and development expenses for 2022 were $0.238B, a 17.51% increase from 2021.
- Sysmex ADR annual research and development expenses for 2021 were $0.203B, a 1.61% increase from 2020.
| Sysmex ADR Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $230 |
| 2022 | $238 |
| 2021 | $203 |
| 2020 | $200 |
| 2019 | $176 |
| 2018 | $158 |
| 2017 | $139 |
| 2016 | $0 |
| Sysmex ADR Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-06-30 | $52 |
| 2022-06-30 | $53 |
| 2021-06-30 | $50 |
| 2020-06-30 | $46 |
| 2019-06-30 | $45 |
| 2018-06-30 | $39 |
| 2017-06-30 | $33 |
| 2016-06-30 | $36 |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.077B | $3.039B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $227.236B | 27.53 |
| Intuitive Surgical (ISRG) | United States | $141.461B | 85.22 |
| Edwards Lifesciences (EW) | United States | $53.716B | 34.96 |
| DexCom (DXCM) | United States | $52.240B | 79.13 |
| IDEXX Laboratories (IDXX) | United States | $44.882B | 52.61 |
| Alcon (ALC) | Switzerland | $43.802B | 31.39 |
| IQVIA Holdings (IQV) | United States | $42.121B | 24.44 |
| STERIS (STE) | Ireland | $22.993B | 26.87 |
| Waters (WAT) | United States | $21.115B | 31.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
| Hologic (HOLX) | United States | $17.508B | 19.59 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.893B | 15.05 |
| ShockWave Medical (SWAV) | United States | $12.394B | 77.13 |
| Teleflex (TFX) | United States | $10.251B | 15.96 |
| Globus Medical (GMED) | United States | $8.718B | 25.56 |
| Penumbra (PEN) | United States | $7.890B | 89.66 |
| Masimo (MASI) | United States | $6.588B | 37.95 |
| Glaukos (GKOS) | United States | $5.530B | 0.00 |
| TransMedics (TMDX) | United States | $4.545B | 431.19 |
| Integer Holdings (ITGR) | United States | $4.051B | 24.48 |
| PROCEPT BioRobotics (PRCT) | United States | $3.502B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.355B | 19.92 |
| Tandem Diabetes Care (TNDM) | United States | $3.055B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.926B | 20.07 |
| Inari Medical (NARI) | United States | $2.660B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.485B | 21.02 |
| RxSight (RXST) | United States | $2.243B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.170B | 9.46 |
| Veracyte (VCYT) | United States | $1.749B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.546B | 0.00 |
| Artivion (AORT) | United States | $0.978B | 93.84 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.936B | 18.20 |
| OPKO Health (OPK) | United States | $0.920B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.875B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.763B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.659B | 22.39 |
| Paragon 28 (FNA) | United States | $0.635B | 0.00 |
| SiBone (SIBN) | United States | $0.615B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.563B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.550B | 0.00 |
| IRadimed (IRMD) | United States | $0.532B | 29.81 |
| Pulse Biosciences (PLSE) | United States | $0.431B | 0.00 |
| Nevro (NVRO) | United States | $0.419B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.326B | 11.16 |
| Treace Medical Concepts (TMCI) | United States | $0.310B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
| AxoGen (AXGN) | United States | $0.264B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.249B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| 908 Devices (MASS) | United States | $0.236B | 0.00 |
| NeuroPace (NPCE) | United States | $0.235B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.210B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.197B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.170B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.163B | 8.25 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.108B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.097B | 20.45 |
| Yubo Biotech (YBGJ) | China | $0.095B | 0.00 |
| Neuronetics (STIM) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.064B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.062B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| DarioHealth (DRIO) | United States | $0.057B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.047B | 0.00 |
| LENSAR (LNSR) | United States | $0.047B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.033B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.031B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.029B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |